Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Tocilizumab in COVID-19 therapy: who benefits, and how? - Authors' reply.

Working paper

Horby P. et al, (2021), Lancet, 398

Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis.

Journal article

WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group None. et al, (2021), JAMA

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

Journal article

RECOVERY Collaborative Group None., (2021), Lancet, 397, 1637 - 1645

Dexamethasone in Hospitalized Patients with Covid-19.

Journal article

RECOVERY Collaborative Group None. et al, (2021), N Engl J Med, 384, 693 - 704

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

Journal article

RECOVERY Collaborative Group None., (2021), Lancet, 397, 605 - 612

Development and Internal Validation of a Risk Score to Detect Asymptomatic Carotid Stenosis.

Journal article

Poorthuis MHF. et al, (2021), Eur J Vasc Endovasc Surg

Conventional and Genetic Evidence on the Association between Adiposity and CKD.

Journal article

Zhu P. et al, (2020), J Am Soc Nephrol

Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Journal article

RECOVERY Collaborative Group None., (2020), Lancet. 2020;396(10259):1345-52.

Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.

Journal article

RECOVERY Collaborative Group None. et al, (2020), N Engl J Med

Load More